Travere Therapeutics (TVTX) Stock Chart & Stock Price History → Options expert shares his top option strategy for free (From WealthPress) (Ad) Free TVTX Stock Alerts $7.02 -0.11 (-1.54%) (As of 10:21 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Travere Therapeutics Stock Price Performance5 Day Performance-8.94%1 Month Performance+13.17%3 Month Performance-17.67%6 Month Performance-17.48%Year-To-Date Performance-20.69%1 Year Performance-57.23% Receive TVTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. TVTX Stock Chart for Monday, June, 10, 2024 TVTX Chart by TradingView Travere Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$7.23$7.13-1.38%$7.27$6.98625,264 shs$542.81 million06/06/2024$7.83$7.23-7.66%$7.81$7.22690,658 shs$550.42 million06/05/2024$7.67$7.83+2.09%$7.85$7.46734,379 shs$596.10 million06/04/2024$7.72$7.67-0.65%$7.91$7.55761,631 shs$583.92 million06/03/2024$7.42$7.72+4.04%$7.99$7.351.49 million shs$587.72 million05/31/2024$7.02$7.42+5.70%$7.60$7.031.09 million shs$564.89 million Get the Latest News and Ratings for TVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$6.84$7.02+2.63%$7.19$6.791.07 million shs$534.43 million05/29/2024$6.76$6.84+1.18%$6.88$6.501.03 million shs$520.73 million05/28/2024$6.16$6.76+9.74%$7.02$6.301.32 million shs$514.64 million05/27/2024$6.16$6.16$6.39$6.14591,800 shs$468.96 million05/24/2024$6.34$6.16-2.84%$6.39$6.14591,453 shs$468.96 million05/23/2024$6.56$6.34-3.35%$6.56$6.231.15 million shs$482.66 million05/22/2024$6.61$6.56-0.76%$6.67$6.42811,497 shs$499.41 million05/21/2024$6.17$6.61+7.13%$6.65$6.141.29 million shs$503.22 million05/20/2024$6.06$6.17+1.82%$6.22$6.01909,628 shs$469.72 million05/17/2024$6.69$6.06-9.42%$6.67$6.031.32 million shs$461.35 million05/16/2024$6.80$6.69-1.62%$7.09$6.60930,732 shs$509.30 million05/15/2024$6.70$6.80+1.49%$7.19$6.781.03 million shs$517.68 million05/14/2024$6.34$6.70+5.68%$6.72$6.451.12 million shs$510.07 million05/13/2024$6.30$6.34+0.63%$6.56$6.22792,503 shs$482.66 million05/10/2024$6.60$6.30-4.55%$6.88$6.26974,662 shs$479.49 million05/09/2024$6.82$6.60-3.23%$6.87$6.581.20 million shs$502.33 million05/08/2024$6.75$6.82+1.04%$6.94$6.491.23 million shs$519.07 million05/07/2024$6.55$6.75+3.05%$7.69$6.741.94 million shs$513.74 million05/06/2024$6.26$6.55+4.63%$6.58$6.211.38 million shs$498.51 million05/03/2024$6.16$6.26+1.62%$6.56$6.18767,565 shs$476.45 million05/02/2024$6.00$6.16+2.67%$6.21$5.79823,572 shs$468.84 million05/01/2024$5.53$6.00+8.50%$6.11$5.541.88 million shs$456.65 million04/30/2024$5.46$5.53+1.28%$5.76$5.301.32 million shs$420.89 million04/29/2024$5.26$5.46+3.80%$5.57$5.241.58 million shs$415.56 million04/26/2024$5.39$5.26-2.41%$5.56$5.211.22 million shs$400.34 million04/25/2024$5.45$5.39-1.10%$5.50$5.121.48 million shs$410.23 million04/24/2024$5.74$5.45-5.05%$5.78$5.341.98 million shs$414.80 million04/23/2024$5.85$5.74-1.88%$5.96$5.711.24 million shs$436.87 million04/22/2024$5.72$5.85+2.27%$5.94$5.711.10 million shs$445.24 million04/19/2024$5.80$5.72-1.38%$5.91$5.58946,701 shs$435.35 million04/18/2024$5.99$5.80-3.17%$6.02$5.78972,249 shs$441.44 million04/17/2024$6.15$5.99-2.60%$6.34$5.941.31 million shs$455.89 million04/16/2024$6.32$6.15-2.69%$6.36$6.11747,661 shs$468.08 million04/15/2024$6.37$6.32-0.78%$6.49$6.201.55 million shs$481.02 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/12/2024$6.69$6.37-4.78%$6.70$6.25937,230 shs$484.82 million04/11/2024$6.67$6.69+0.30%$6.85$6.521.90 million shs$509.18 million04/10/2024$6.86$6.67-2.77%$6.80$6.433.59 million shs$507.65 million04/09/2024$6.96$6.86-1.44%$7.26$6.82755,094 shs$522.12 million04/08/2024$7.04$6.96-1.14%$7.14$6.94534,602 shs$529.73 million04/05/2024$6.95$7.04+1.29%$7.13$6.65715,668 shs$535.81 million04/04/2024$6.98$6.95-0.43%$7.17$6.921.08 million shs$528.96 million04/03/2024$7.04$6.98-0.85%$7.15$6.871.25 million shs$531.25 million04/02/2024$7.31$7.04-3.69%$7.34$7.001.05 million shs$535.81 million04/01/2024$7.71$7.31-5.19%$7.77$7.251.07 million shs$556.36 million03/29/2024$7.71$7.71$7.98$7.41776,017 shs$586.73 million03/28/2024$7.67$7.71+0.52%$7.97$7.41776,017 shs$586.73 million03/27/2024$7.57$7.67+1.32%$8.06$7.111.10 million shs$583.69 million03/26/2024$7.69$7.57-1.56%$7.95$7.54988,583 shs$576.08 million03/25/2024$7.88$7.69-2.41%$8.12$7.69625,928 shs$585.21 million03/22/2024$8.09$7.88-2.60%$8.14$7.83952,352 shs$599.67 million03/21/2024$7.76$8.09+4.25%$8.41$7.721.03 million shs$615.65 million03/20/2024$7.48$7.76+3.74%$7.84$7.341.00 million shs$590.54 million03/19/2024$7.18$7.48+4.18%$7.52$7.111.33 million shs$569.23 million03/18/2024$7.49$7.18-4.14%$7.47$7.141.17 million shs$546.40 million03/15/2024$7.53$7.49-0.53%$7.81$7.462.33 million shs$569.99 million03/14/2024$8.15$7.53-7.61%$8.11$7.491.01 million shs$573.02 million03/13/2024$7.75$8.15+5.16%$8.39$7.711.18 million shs$620.20 million03/12/2024$7.99$7.75-3.00%$8.07$7.68978,074 shs$589.78 million03/11/2024$8.66$7.99-7.74%$8.72$7.971.12 million shs$608.04 million Related Companies: Harrow Stock Chart Omeros Stock Chart Rigel Pharmaceuticals Stock Chart Deciphera Pharmaceuticals Stock Chart Maravai LifeSciences Stock Chart Rhythm Pharmaceuticals Stock Chart Geron Stock Chart Vera Therapeutics Stock Chart Amphastar Pharmaceuticals Stock Chart Agios Pharmaceuticals Stock Chart Receive TVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVTX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.